Research
Prognostic role of 18FDG-PET/CT based biomarker, tumor grading and immunohistochemical markers in breast cancer survival
Nature ·
The Brief
- A study examines the prognostic role of 18FDG-PET/CT-based biomarkers in breast cancer survival.
- The study also assesses tumor grading and immunohistochemical markers as survival predictors.
- The article is listed on nature.com with the identifier s41598-026-76747-8; no summary was provided.
Why it matters
It tests whether imaging-derived biomarkers, alongside standard tumor grading and immunohistochemistry, can help predict breast cancer survival, which matters for researchers developing prognostic tools.
Who’s affected
- Researchers in breast cancer prognosis and PET/CT imaging
- #breast cancer
- #pet-ct
- #prognosis
- #biomarkers
- #oncology